Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease

被引:77
|
作者
Lad, Eleonora M. [1 ]
Mukherjee, Dibyendu [2 ]
Stinnett, Sandra S. [1 ]
Cousins, Scott W. [1 ]
Potter, Guy G. [3 ]
Burke, James R. [3 ]
Farsiu, Sina [1 ,2 ]
Whitson, Heather E. [1 ,4 ]
机构
[1] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA
[3] Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源
PLOS ONE | 2018年 / 13卷 / 02期
关键词
OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; SMALL VESSEL DISEASE; VISUAL-FIELD LOSS; AUTOMATIC SEGMENTATION; MULTIPLE-SCLEROSIS; SD-OCT; THICKNESS; DYSFUNCTION; DEMENTIA;
D O I
10.1371/journal.pone.0192646
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inner retina in Alzheimer's Disease (AD) may experience neuroinflammation resulting in atrophy. The objective of our study was to determine whether retinal GCIPL (ganglion cell-inner plexiform layer) or nerve fiber layer (NFL) thickness may serve as noninvasive bio-markers to diagnose AD. This cross-sectional case-control study enrolled 15 mild cognitive impairment (MCI) patients, 15 mild-moderate AD patients, and 18 cognitively normal adults. NFL and GCIPL thicknesses on optical coherence tomography (OCT) were measured using Duke Optical Coherence Tomography Retinal Analysis Program (DOCTRAP) and Spectralis software. We demonstrated that regional thicknesses of NFL or GCIPL on macular or nerve OCTs did not differ between groups. However, a multi-variate regression analysis identified macular areas with a significant thickening or thinning in NFL and GCIPL in MCI and AD patients. Our primary findings controvert previous reports of thinner NFL in moderate-to-severe AD. The areas of thickening of GCIPL and NFL in the macula adjacent to areas of thinning, as revealed by a more complex statistical model, suggest that NFL and GCIPL may undergo dynamic changes during AD progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Usefulness of candidate mRNAs and miRNAs as biomarkers for mild cognitive impairment and Alzheimer's disease
    Qin, Hongyun
    Hu, Chengping
    Zhao, Xudong
    Tian, Ming
    Zhu, Binggen
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (01) : 89 - 102
  • [42] Diagnostic biomarkers of mild cognitive impairment and Alzheimer's disease: A plasma proteomics approach
    Poljak, A.
    Song, F.
    Jayasena, T.
    Smythe, G.
    Raftery, M.
    Brodaty, H.
    Slavin, M.
    Kochan, N.
    Trollor, J.
    Crawford, J.
    Wen, W.
    Ng, L.
    Sachdev, P.
    AUSTRALASIAN JOURNAL ON AGEING, 2009, 28 : A71 - A72
  • [43] Early Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: Imaging, Biomarkers, and Technology
    Buracchio, Teresa
    Kaye, Jeffrey
    GENERATIONS-JOURNAL OF THE AMERICAN SOCIETY ON AGING, 2009, 33 (01): : 18 - 23
  • [44] Chemokine serum levels in mild cognitive impairment as Alzheimer's disease early biomarkers
    Galimberti, D.
    Fenogli, C.
    Lovati, C.
    Venturelli, E.
    Guidi, I.
    Corra, B.
    Scalabrini, D.
    Clerici, F.
    Mariani, C.
    Bresolin, N.
    Scarpini, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 31 - 32
  • [45] Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
    Magalhaes, T. N. C.
    Weiler, M.
    Teixeira, C. V. L.
    Hayata, T.
    Moraes, A. S.
    Boldrini, V. O.
    dos Santos, L. M.
    de Campos, B. M.
    de Rezende, T. J. R.
    Joaquim, H. P. G.
    Talib, L. L.
    Forlenza, O. V.
    Cendes, F.
    Balthazar, Marcio L. F.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (07) : 5689 - 5697
  • [46] Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
    T. N. C. Magalhães
    M. Weiler
    C. V. L. Teixeira
    T. Hayata
    A. S. Moraes
    V. O. Boldrini
    L. M. dos Santos
    B. M. de Campos
    T. J. R. de Rezende
    H. P. G. Joaquim
    L. L. Talib
    O. V. Forlenza
    F. Cendes
    Marcio L. F. Balthazar
    Molecular Neurobiology, 2018, 55 : 5689 - 5697
  • [47] Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid of Spanish Patients With Mild Cognitive Impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Borja, E. Rodriguez
    Ruiz-Vegara, M.
    Montoya-Gutierrez, F. J.
    Leiva-Santana, C.
    NEUROCHEMICAL RESEARCH, 2011, 36 (06) : 986 - 993
  • [48] Biomarkers of Alzheimer′s Disease in the Cerebrospinal Fluid of Spanish Patients With Mild Cognitive Impairment
    J. A. Monge-Argilés
    C. Muñoz-Ruiz
    A. Pampliega-Pérez
    M. J. Gómez-López
    J. Sánchez-Payá
    E. Rodríguez Borja
    M. Ruiz-Vegara
    F. J. Montoya-Gutiérrez
    C. Leiva-Santana
    Neurochemical Research, 2011, 36 : 986 - 993
  • [49] Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment
    Giuseppe Querques
    Enrico Borrelli
    Riccardo Sacconi
    Luigi De Vitis
    Letizia Leocani
    Roberto Santangelo
    Giuseppe Magnani
    Giancarlo Comi
    Francesco Bandello
    Scientific Reports, 9
  • [50] Retinal oxygen metabolism is altered in patients with mild cognitive impairment and Alzheimer's disease
    Szegedi, Stephan
    Dal-Bianco, Peter
    Stoegmann, Elisabeth
    Traub-Weidinger, Tatjana
    Rainer, Michael
    Masching, Andreas
    Schmidl, Doreen
    Werkmeister, Rene M.
    Schmetterer, Leopold
    Garhofer, Gerhard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)